SMYD1 and cardiac hypertrophy: In the adult myocardium, the loss of Smyd1 using inducible, cardiomyocyte-specific Smyd1 knockout mice leads to the massive downregulation of mitochondrial bioenergetics [27], cardiac hypertrophy, fibrosis and heart failure [32].